SEC Form 4 · accession 0001437749-16-033586
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Hemmeter
Officer — Chief Executive Officer
Period of report
Jun 7, 2016
Accepted (ET)
Jun 9, 2016 · 1:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 7, 2016 | M | 10,000 | $11.54 | A | 24,171 | D | |
| Common StockF3,F2 | Jun 7, 2016 | M | 3,758 | — | D | 20,413 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Unit (RSU)F2,F1 | — | Jun 7, 2016 | M | 10,000 | D | Jun 7, 2016 | Jun 7, 2016 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Restricted Stock Units vested on June 7, 2016.
- F2The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis
- F3Ms Hemmeter surrendered to the Issuer the right to receive an aggregate of 3,758 shares of Common Stock. Ms. Hemmeter did not sell any shares of Common Stock in connection with the foregoing exercise.